4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-069994
EVP, Research & CSO sold 4,125 shares at an average $48.63 ($200,585)
- EVP, Research & CSO acquired 4,125 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Virgin Herbert · EVP, Research & CSO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-12-14 | Exercise or conversion : show line 1 in the form | +1,375 | $1.53 | $2,104 | 109,075 | D |
| 2021-12-14 | Sale : show line 2 in the form | −1,375 | $45.88 | $63,085 | 107,700 | D |
| 2021-12-15 | Exercise or conversion : show line 3 in the form | +2,750 | $1.53 | $4,208 | 110,450 | D |
| 2021-12-15 | Sale : show line 4 in the form | −2,750 | $50.00 | $137,500 | 107,700 | D |
| Open-market sales · 4,125 sh · avg $48.63 · $200,585 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-12-14 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −1,375 | 229,130 | D |
| 2021-12-15 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −2,750 | 226,380 | D |
Loading xslF345X03/doc4.xml…